Analysis of human antibodies to erythrocyte binding antigen 175 of Plasmodium falciparum
about
Distribution of the two forms of Plasmodium falciparum erythrocyte binding antigen-175 (eba-175) gene in Lao PDRAllelic dimorphism of the erythrocyte binding antigen-175 (eba-175) gene of Plasmodium falciparum and severe malaria: Significant association of the C-segment with fatal outcome in Ghanaian childrenStructural and Functional Basis for Inhibition of Erythrocyte Invasion by Antibodies that Target Plasmodium falciparum EBA-175Protective human immunity as a vaccine discovery tool for falciparum malaria.Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3.The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis.Acquisition of antibody isotypes against Plasmodium falciparum blood stage antigens in a birth cohortPopulation genetic analysis of large sequence polymorphisms in Plasmodium falciparum blood-stage antigens.Distinct Th1- and Th2-Type prenatal cytokine responses to Plasmodium falciparum erythrocyte invasion ligands.Safety and immunogenicity of a recombinant nonglycosylated erythrocyte binding antigen 175 Region II malaria vaccine in healthy adults living in an area where malaria is not endemicCritical glycosylated residues in exon three of erythrocyte glycophorin A engage Plasmodium falciparum EBA-175 and define receptor specificity.Subclass responses and their half-lives for antibodies against EBA175 and PfRh2 in naturally acquired immunity against Plasmodium falciparum malaria.Analysis of human antibodies to erythrocyte binding antigen 175 peptide 4 of Plasmodium falciparum.Erythrocyte invasion phenotypes of Plasmodium falciparum in The Gambia.Repeat sequences in block 2 of Plasmodium falciparum merozoite surface protein 1 are targets of antibodies associated with protection from malariaEvidence for erythrocyte-binding antigen 175 as a component of a ligand-blocking blood-stage malaria vaccine.Antibody levels to multiple malaria vaccine candidate antigens in relation to clinical malaria episodes in children in the Kasena-Nankana district of Northern Ghana.The effect of daily co-trimoxazole prophylaxis on natural development of antibody-mediated immunity against P. falciparum malaria infection in HIV-exposed uninfected Malawian childrenImpact of the RTS,S malaria vaccine candidate on naturally acquired antibody responses to multiple asexual blood stage antigensMeasurement of antibody levels against region II of the erythrocyte-binding antigen 175 of Plasmodium falciparum in an area of malaria holoendemicity in western KenyaAntibodies to Plasmodium falciparum erythrocyte-binding antigen-175 are associated with protection from clinical malaria.Age-dependent IgG subclass responses to Plasmodium falciparum EBA-175 are differentially associated with incidence of malaria in Mozambican children.Effect of codon optimization on expression levels of a functionally folded malaria vaccine candidate in prokaryotic and eukaryotic expression systemsAnti-Plasmodium falciparum invasion ligand antibodies in a low malaria transmission region, Loreto, Peru.Duration of naturally acquired antibody responses to blood-stage Plasmodium falciparum is age dependent and antigen specificBreadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malariaHow Should Antibodies against P. falciparum Merozoite Antigens Be Measured?Antibody reactivity to linear epitopes of Plasmodium falciparum cytoadherence-linked asexual gene 9 in asymptomatic children and adults from papua new GuineaLow prevalence of antibodies to preerythrocytic but not blood-stage Plasmodium falciparum antigens in an area of unstable malaria transmission compared to prevalence in an area of stable malaria transmission.Inhibitory humoral responses to the Plasmodium falciparum vaccine candidate EBA-175 are independent of the erythrocyte invasion pathway.Erythrocyte-binding antigens of Plasmodium falciparum are targets of human inhibitory antibodies and function to evade naturally acquired immunity.Functional and immunological characterization of a Duffy binding-like alpha domain from Plasmodium falciparum erythrocyte membrane protein 1 that mediates rosetting.High levels of IgG3 anti ICB2-5 in Plasmodium vivax-infected individuals who did not develop symptoms.A quantitative assay for binding and inhibition of Plasmodium falciparum Erythrocyte Binding Antigen 175 reveals high affinity binding depends on both DBL domains.Evidence for diversifying selection on erythrocyte-binding antigens of Plasmodium falciparum and P. vivax.An evolutionary approach to identify potentially protective B cell epitopes involved in naturally acquired immunity to malaria and the role of EBA-175 in protection amongst denizens of Bolifamba, Cameroon.Extensive antigenic polymorphism within the repeat sequence of the Plasmodium falciparum merozoite surface protein 1 block 2 is incorporated in a minimal polyvalent immunogen.Acquisition, maintenance and adaptation of invasion inhibitory antibodies against Plasmodium falciparum invasion ligands involved in immune evasion.Natural antibody response to Plasmodium falciparum Exp-1, MSP-3 and GLURP long synthetic peptides and association with protection.Variation in the immune responses against Plasmodium falciparum merozoite surface protein-1 and apical membrane antigen-1 in children residing in the different epidemiological strata of malaria in Cameroon.
P2860
Q24792618-F9F01711-7330-48EC-98DF-B9549CA79E30Q24806782-CE46370B-024F-4EC9-9A85-5576EAF5BE64Q27678372-74B52FD5-1702-44C1-8769-A80E3B38D0D6Q33221295-DBBABE45-303D-4AC7-A221-30B3C93AB36FQ33305467-2557B5E7-337B-4782-B5EF-A1789B8C1F89Q33526349-2F0E6B23-E6BA-4C03-9D5A-3A9229B0B408Q33621604-AE492037-2DAC-4727-AA5C-B8AA4993A661Q33691419-C526A36A-058D-4DA9-8E70-4C45C1CDE816Q33788247-219A22E7-CF7C-4A33-AEC8-B66B1DB4AF53Q34189972-2046DAF1-2491-4930-9B36-9D5D03550DA3Q34237880-6B842457-3C2F-45EA-B9C0-9D430E25094EQ34515219-B586938C-1AF9-4B80-A8BE-C5EEB9731A94Q34537136-84D6C317-DE58-4101-8A62-4D753606978DQ34850940-C2C3F011-55D6-4DF3-A35D-4173FE4A0AA2Q34855814-F252757C-54A2-4E9D-A8C6-F306145E95F1Q34937705-5F101460-4FCD-46CB-AA72-F3DD7987A6F4Q35003931-298315C7-8EBD-4AB5-9F4F-8EB05FCAE776Q35217416-1F21E0A6-664E-4402-8DAE-DDA5404F132CQ35330733-9A897B11-F2A6-47B9-A04E-220D805147ABQ35550197-AE32DBF1-FF8A-4631-A5C1-FBBAE4B708E9Q35569042-C373F030-5521-4890-9275-A7D58681368BQ35739071-4195D04D-6421-4791-8B04-48AA87495CFAQ35802357-4E1E3DD8-046C-4B0F-B2BF-AE1015B9086BQ36531268-ECC023A6-5076-4927-B9EC-A9BA16B01499Q36539692-F04739E1-A3A3-4610-87D2-E919567C5D15Q36594057-515B0133-9A9D-4666-B0D4-0FFE319ED2F9Q36838314-BEA14E7A-2D37-48C8-B8D8-6EF96DCAB772Q36867750-A7DA9CA7-CB06-4CDE-A28E-96986F96DF27Q36974401-85E8C021-8134-48C3-B6F8-7E019EC01DBCQ37124750-46249D24-DBA4-4E87-ABAB-E83EAEB04C01Q37202344-6E5D7B15-76B0-42BA-9971-90350583E7F3Q37333406-691DD472-3920-41D2-BA4F-FDD8D1931ED3Q37352099-007CEE15-008B-4023-8292-22E2DD7BE47DQ37632441-8C5C4DEC-D5A4-4375-8770-0EA3F7009A85Q38897395-C2314B63-FD04-47F2-8723-1B0E1684D13EQ39313046-8018CE12-D93C-4E53-A009-93172AAC83C4Q39518664-ED185E37-DED2-44AE-BBF7-24D2E87C3410Q40102134-86E255DA-7033-4BFC-9F8E-27E83CC833F1Q43933739-952D0611-8D6E-4FAB-B980-506BC947B96FQ46161949-078BD792-8B2A-4AA9-BA52-6C91C7F8295C
P2860
Analysis of human antibodies to erythrocyte binding antigen 175 of Plasmodium falciparum
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Analysis of human antibodies to erythrocyte binding antigen 175 of Plasmodium falciparum
@ast
Analysis of human antibodies to erythrocyte binding antigen 175 of Plasmodium falciparum
@en
type
label
Analysis of human antibodies to erythrocyte binding antigen 175 of Plasmodium falciparum
@ast
Analysis of human antibodies to erythrocyte binding antigen 175 of Plasmodium falciparum
@en
prefLabel
Analysis of human antibodies to erythrocyte binding antigen 175 of Plasmodium falciparum
@ast
Analysis of human antibodies to erythrocyte binding antigen 175 of Plasmodium falciparum
@en
P2093
P2860
P1476
Analysis of human antibodies to erythrocyte binding antigen 175 of Plasmodium falciparum
@en
P2093
J R Daugherty
Q D Bickle
P2860
P304
P356
10.1128/IAI.68.10.5559-5566.2000
P407
P577
2000-10-01T00:00:00Z